VERTEX PHARMACEUTICALS INC / MA Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 500,000 | |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 26,500 | |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 120.58 | 1,200 | 144,696 | 336,395 | 337.6 K to 336.4 K (-0.36 %) |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 119.56 | 2,900 | 346,724 | 337,595 | 340.5 K to 337.6 K (-0.85 %) |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 118.66 | 7,300 | 866,218 | 340,495 | 347.8 K to 340.5 K (-2.10 %) |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 116.89 | 300 | 35,067 | 347,795 | 348.1 K to 347.8 K (-0.09 %) |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 348,095 | 337.7 K to 348.1 K (+3.08 %) |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 337,695 | 336.4 K to 337.7 K (+0.39 %) |
| Feb 27 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Gift | G | 0.00 | 2,500 | 0 | 336,395 | 338.9 K to 336.4 K (-0.74 %) |
| Feb 25 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 77.31 | 1,290 | 99,730 | 15,468 | |
| Feb 25 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 83.36 | 860 | 71,690 | 8,593 | |
| Feb 25 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 119.85 | 2,150 | 257,678 | 20,625 | 22.8 K to 20.6 K (-9.44 %) |
| Feb 25 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 77.31 | 1,290 | 99,730 | 22,775 | 21.5 K to 22.8 K (+6.00 %) |
| Feb 25 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 83.36 | 860 | 71,690 | 21,485 | 20.6 K to 21.5 K (+4.17 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 510,400 | |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 27,800 | |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 113.30 | 4,600 | 521,180 | 338,895 | 343.5 K to 338.9 K (-1.34 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 112.87 | 7,100 | 801,377 | 343,495 | 350.6 K to 343.5 K (-2.03 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 350,595 | 340.2 K to 350.6 K (+3.06 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 340,195 | 338.9 K to 340.2 K (+0.38 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 113.16 | 1,449 | 163,969 | 20,625 | 22.1 K to 20.6 K (-6.56 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 112.71 | 1,988 | 224,067 | 22,074 | 24.1 K to 22.1 K (-8.26 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 113.14 | 3,137 | 354,920 | 89,984 | 93.1 K to 90 K (-3.37 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 112.62 | 2,800 | 315,336 | 93,121 | 95.9 K to 93.1 K (-2.92 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 113.13 | 5,100 | 576,963 | 124,176 | 129.3 K to 124.2 K (-3.95 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 112.66 | 5,250 | 591,465 | 129,276 | 134.5 K to 129.3 K (-3.90 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 113.14 | 15,250 | 1,725,385 | 249,927 | 265.2 K to 249.9 K (-5.75 %) |
| Feb 20 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 112.67 | 17,000 | 1,915,390 | 265,177 | 282.2 K to 265.2 K (-6.02 %) |
| Feb 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 520,800 | |
| Feb 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 29,100 | |
| Feb 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 109.94 | 200 | 21,988 | 338,895 | 339.1 K to 338.9 K (-0.06 %) |
| Feb 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 108.87 | 3,100 | 337,497 | 339,095 | 342.2 K to 339.1 K (-0.91 %) |
| Feb 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 108.20 | 2,400 | 259,680 | 342,195 | 344.6 K to 342.2 K (-0.70 %) |
| Feb 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 344,595 | 340.2 K to 344.6 K (+1.29 %) |
| Feb 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 340,195 | 338.9 K to 340.2 K (+0.38 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 525,200 | |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 30,400 | |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 110.15 | 700 | 77,105 | 338,895 | 339.6 K to 338.9 K (-0.21 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 109.30 | 3,700 | 404,410 | 339,595 | 343.3 K to 339.6 K (-1.08 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 108.18 | 500 | 54,090 | 343,295 | 343.8 K to 343.3 K (-0.15 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 106.51 | 300 | 31,953 | 343,795 | 344.1 K to 343.8 K (-0.09 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 105.34 | 500 | 52,670 | 344,095 | 344.6 K to 344.1 K (-0.15 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 344,595 | 340.2 K to 344.6 K (+1.29 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 340,195 | 338.9 K to 340.2 K (+0.38 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 45.11 | 1,688 | 76,146 | 13,500 | |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 110.76 | 388 | 42,975 | 24,062 | 24.5 K to 24.1 K (-1.59 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 109.74 | 900 | 98,766 | 24,450 | 25.4 K to 24.5 K (-3.55 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 108.81 | 400 | 43,524 | 25,350 | 25.8 K to 25.4 K (-1.55 %) |
| Feb 06 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 45.11 | 1,688 | 76,146 | 25,750 | 24.1 K to 25.8 K (+7.02 %) |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | A | 109.14 | 20,625 | 2,251,013 | 20,625 | |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Grant | A | 0.01 | 6,875 | 69 | 24,062 | 17.2 K to 24.1 K (+40.00 %) |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | A | 109.14 | 57,500 | 6,275,550 | 57,500 | |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Grant | A | 0.01 | 17,250 | 173 | 95,921 | 78.7 K to 95.9 K (+21.93 %) |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | A | 109.14 | 213,000 | 23,246,820 | 213,000 | |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.01 | 64,500 | 645 | 282,177 | 217.7 K to 282.2 K (+29.63 %) |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | A | 109.14 | 68,000 | 7,421,520 | 68,000 | |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Grant | A | 0.01 | 20,700 | 207 | 138,270 | 117.6 K to 138.3 K (+17.61 %) |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 109.14 | 68,000 | 7,421,520 | 68,000 | |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 20,700 | 207 | 134,526 | 113.8 K to 134.5 K (+18.19 %) |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 109.14 | 57,500 | 6,275,550 | 57,500 | |
| Feb 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.01 | 17,250 | 173 | 100,562 | 83.3 K to 100.6 K (+20.71 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 38.80 | 938 | 36,394 | 0 | |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 37.86 | 1,125 | 42,593 | 4,500 | |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 111.32 | 100 | 11,132 | 17,187 | 17.3 K to 17.2 K (-0.58 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 109.50 | 100 | 10,950 | 17,287 | 17.4 K to 17.3 K (-0.58 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 108.16 | 300 | 32,448 | 17,387 | 17.7 K to 17.4 K (-1.70 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 107.04 | 438 | 46,884 | 17,687 | 18.1 K to 17.7 K (-2.42 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 38.80 | 938 | 36,394 | 18,125 | 17.2 K to 18.1 K (+5.46 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 110.76 | 157 | 17,389 | 17,187 | 17.3 K to 17.2 K (-0.91 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 109.89 | 668 | 73,407 | 17,344 | 18 K to 17.3 K (-3.71 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 108.11 | 300 | 32,433 | 18,012 | 18.3 K to 18 K (-1.64 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 37.86 | 1,125 | 42,593 | 18,312 | 17.2 K to 18.3 K (+6.55 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 110.85 | 100 | 11,085 | 83,312 | 83.4 K to 83.3 K (-0.12 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 109.80 | 788 | 86,522 | 83,412 | 84.2 K to 83.4 K (-0.94 %) |
| Feb 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 108.64 | 300 | 32,592 | 84,200 | 84.5 K to 84.2 K (-0.36 %) |